Re:When the Patient Is a Gold Mine: The Trouble with Rare-Di...
by dmoy on Wednesday May 24, 2017 @08:56PM
(#14414630)
Idk how to break out their financial statement, but in 2016 it looks like they spent a billion dollars on "sales, general, and administration" (distinct from cost of sales (250m) and R&D (750m).
I would imagine something in that billion dollars is marketing...
I would imagine something in that billion dollars is marketing...